A great deal of evidence has revealed an important link between gut microbiota and the
heart. In particular, the gut microbiota plays a key role in the onset of cardiovascular (CV) …

This future perspective analyzes the complex relationship between inflammation and
atherosclerosis and arterial hypertension. The involvement of inflammation in …

Cardiovascular diseases (CVDs), such as arterial hypertension, myocardial infarction,
stroke, heart failure, atrial fibrillation, etc., still represent the main cause of morbidity and …

Chronic heart disease (CHD) is still a major global cause of morbidity and mortality,
necessitating effective therapeutic interventions to mitigate its progression. Omega-3 fatty …

The therapeutic management of atherosclerosis focuses almost exclusively on the reduction
of plasma cholesterol levels. An important role in the genesis and evolution of …

The role of cholesterol, mainly low-density lipoproteins (LDL-C), as a causal risk factor for
atherosclerotic cardiovascular disease (ASCVD) is now established and accepted by the …

Cardiovascular disease stemmed from atherosclerosis (AS) is well recognized to be the
predominant cause of global death. To comprehensively clarify the pathogenesis of AS …

There are a wide variety of phytochemicals collectively known as polyphenols. Their
structural diversity results in a broad range of characteristics and biological effects …

非酒精性脂肪肝(Non-Alcoholic Fatty Liver Disease, NAFLD) 是慢性肝病的主要原因,
被认为是代谢综合征的肝脏表现. NAFLD 与胰岛素抵抗, 肥胖, 血脂异常 …

Background This study aimed to develop a predictive nomogram for long-term outcomes in
patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary …